What is a stock summary page? Click here for an overview.
Business Description
Eyenovia Inc
NAICS : 325412
SIC : 2834
ISIN : US30234E1047
Description
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.55 | |||||
| Equity-to-Asset | 0.16 | |||||
| Debt-to-Equity | 3.5 | |||||
| Debt-to-EBITDA | -0.38 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -16.02 | |||||
| Beneish M-Score | 24.49 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -89.8 | |||||
| 3-Year EBITDA Growth Rate | 14.3 | |||||
| 3-Year EPS without NRI Growth Rate | 11.1 | |||||
| 3-Year FCF Growth Rate | -29 | |||||
| 3-Year Book Growth Rate | -31.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 22.01 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 1369.45 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 15.26 | |||||
| 9-Day RSI | 19.42 | |||||
| 14-Day RSI | 24.53 | |||||
| 3-1 Month Momentum % | -82.06 | |||||
| 6-1 Month Momentum % | -95.91 | |||||
| 12-1 Month Momentum % | -97.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.74 | |||||
| Quick Ratio | 0.55 | |||||
| Cash Ratio | 0.46 | |||||
| Days Inventory | 1141.27 | |||||
| Days Payable | 981.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -22.2 | |||||
| Shareholder Yield % | -1244.77 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -1778.79 | |||||
| Operating Margin % | -110775.76 | |||||
| Net Margin % | -114639.39 | |||||
| FCF Margin % | -92845.45 | |||||
| ROE % | -676.86 | |||||
| ROA % | -143.72 | |||||
| ROIC % | -193.29 | |||||
| 3-Year ROIIC % | 2758.33 | |||||
| ROC (Joel Greenblatt) % | -578.08 | |||||
| ROCE % | -260.94 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 18.83 | |||||
| PB Ratio | 0.28 | |||||
| EV-to-EBIT | -0.22 | |||||
| EV-to-Forward-EBIT | -0.55 | |||||
| EV-to-EBITDA | -0.23 | |||||
| EV-to-Revenue | 237.39 | |||||
| EV-to-Forward-Revenue | 2.04 | |||||
| EV-to-FCF | -0.26 | |||||
| Earnings Yield (Greenblatt) % | -454.55 | |||||
| FCF Yield % | -1524.33 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:EYEN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Eyenovia Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.033 | ||
| EPS (TTM) ($) | -56.8 | ||
| Beta | 0.43 | ||
| 3-Year Sharpe Ratio | -0.56 | ||
| 3-Year Sortino Ratio | -0.76 | ||
| Volatility % | 184.3 | ||
| 14-Day RSI | 24.53 | ||
| 14-Day ATR ($) | 0.174637 | ||
| 20-Day SMA ($) | 1.383535 | ||
| 12-1 Month Momentum % | -97.79 | ||
| 52-Week Range ($) | 0.9597 - 124.8 | ||
| Shares Outstanding (Mil) | 2.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Eyenovia Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Eyenovia Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Eyenovia Inc Frequently Asked Questions
What is Eyenovia Inc(EYEN)'s stock price today?
The current price of EYEN is $0.96. The 52 week high of EYEN is $124.80 and 52 week low is $0.96.
When is next earnings date of Eyenovia Inc(EYEN)?
The next earnings date of Eyenovia Inc(EYEN) is 2025-04-08 Est..
Does Eyenovia Inc(EYEN) pay dividends? If so, how much?
Eyenovia Inc(EYEN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers